Coherus Oncology Expands Clinical Program and Reports Third Quarter Financial Results
November 7, 2025 - 04:23
Coherus Oncology has announced an expansion of its clinical program for CHS-114, a highly selective Treg depleter, to include colorectal cancer. This strategic move aims to broaden the therapeutic applications of its innovative treatment and potentially enhance patient outcomes in this challenging area of oncology.
For the third quarter of 2025, the company reported robust financial results, ending the period with cash, cash equivalents, and marketable securities totaling $191.7 million. This solid financial foundation positions Coherus for future growth and development in its clinical endeavors.
Additionally, the company reported net revenue from LOQTORZI® of $11.2 million, representing a 12% increase compared to the previous quarter. This growth reflects the increasing demand for its products and the effectiveness of its marketing strategies.
A conference call is scheduled for today at 5:00 p.m. Eastern Standard Time, where company executives will discuss these results in more detail and provide insights into future initiatives.
MORE NEWS
February 24, 2026 - 21:58
Mpls Fed survey: Upper Midwest businesses report falling profits, tariff uncertaintyA recent survey conducted by the Federal Reserve Bank of Minneapolis reveals a concerning trend of falling profits across the Ninth District, which encompasses the Upper Midwest. Businesses from...
February 24, 2026 - 05:04
Widespread boil water advisory prompts businesses to closeA major boil water advisory has swept through the city, leading to the immediate closure of numerous restaurants, cafes, and other businesses reliant on safe tap water. City officials confirmed the...
February 23, 2026 - 18:50
NYC mayor threatens property tax hike, raising concerns for businessesA proposed property tax hike from New York City`s mayor is generating significant concern among the city`s business community. The initiative, aimed at addressing a substantial budget shortfall,...
February 23, 2026 - 12:25
Media Buying Briefing: Dentsu’s new CEO on how he’s going to grow the business againTakeshi Sano has assumed the role of global CEO at Dentsu, signaling a strategic shift for the advertising holding company. Sano brings a distinctly more outgoing and worldly approach to leadership...